Gamma Knife Radiosurgery for Trigeminal Neuralgia
(URGEnt-TN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores Gamma Knife Radiosurgery to determine its effectiveness for trigeminal neuralgia (TN), a condition causing severe facial pain. Researchers aim to discover if earlier use of this treatment can offer longer-lasting pain relief and reduce reliance on high-dose medications. Participants will either continue their usual treatment or receive the Gamma Knife procedure. The trial seeks individuals who have experienced TN pain for less than two years and have tried medication without needing increased dosages. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group of participants.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications, but you must be on a stable dose for at least 3 months before joining. This suggests you may continue your current medications if they meet this condition.
What prior data suggests that Gamma Knife stereotactic radiosurgery is safe for treating trigeminal neuralgia?
Research has shown that Gamma Knife radiosurgery (GK-SRS) for trigeminal neuralgia (TN) is generally well-tolerated by patients. Studies have found that it provides good pain relief for many individuals. Specifically, about 69-85% of patients experienced pain relief after one year, and 59% maintained relief after two years. However, effectiveness may decrease over time, with approximately 38-52% continuing to feel relief after five years.
Safety information indicates that GK-SRS is a safe option, as it typically does not cause serious side effects. Starting treatment with Gamma Knife earlier might lead to faster pain relief, especially for those who haven't undergone surgery before. While no major safety issues have been reported, individual experiences can vary. Participants should discuss any concerns with their healthcare provider.12345Why do researchers think this study treatment might be promising for trigeminal neuralgia?
Gamma Knife stereotactic radiosurgery is unique because it offers a non-invasive alternative for treating trigeminal neuralgia. Unlike traditional surgical options that might involve incisions or altering nerve pathways, this technique uses highly focused radiation to target and disrupt the nerve causing the pain. Researchers are excited because this method minimizes the risks associated with open surgery and can be precisely controlled, potentially resulting in fewer side effects and a quicker recovery.
What evidence suggests that Gamma Knife stereotactic radiosurgery is effective for trigeminal neuralgia?
Studies have shown that Gamma Knife radiosurgery can effectively treat trigeminal neuralgia, a condition causing severe facial pain. In one study, 86% of patients initially reported improvement, and 77% experienced significant pain relief over time. Another study found that 66.6% to 100% of patients became pain-free shortly after treatment. Overall, most patients reported good to excellent results, even when other treatments failed. In this trial, participants will either receive Gamma Knife radiosurgery or continue their medical management as determined by their treating physician. This suggests that Gamma Knife radiosurgery can provide substantial pain relief for many with this condition.16789
Are You a Good Fit for This Trial?
This trial is for individuals with trigeminal neuralgia, a type of neuropathic facial pain. Participants should be candidates for an early treatment approach and willing to undergo various assessments including MRI, heart rate and blood pressure measurements, as well as answer health-related questionnaires.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Gamma Knife stereotactic radiosurgery (GK-SRS) for trigeminal neuralgia
Follow-up
Participants are monitored for safety and effectiveness after treatment
Questionnaire and Assessment
Participants complete medical histories, neurological examinations, and various health questionnaires
What Are the Treatments Tested in This Trial?
Interventions
- Gamma Knife Stereotactic Radiosurgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor